Skip to main content
Terug
Watch Compare

Coeptis Therapeutics Holdings, Inc.

Datakwaliteit: 100%
Ook genoteerd als COEPW Nasdaq
COEP
Nasdaq Financial Services Nondepository Credit Institutions
€ 12,56
▲ € 1,71 (15,76%)
Marktkapitalisatie: 78,16 M
Prijs
€ 12,56
Marktkapitalisatie
78,16 M
Dagbereik
€ 10,94 — € 12,60
52-Weeksbereik
€ 6,26 — € 21,41
Volume
64.246
Openen € 10,94
50D / 200D Gem.
€ 12,09
3,85% above
50D / 200D Gem.
€ 13,18
4,68% below

Quick Summary

Belangrijkste Punten

Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -8,60 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-144,79%
Onder sectorgemiddelde (9,24%)
ROIC-107,38%
Net Margin-874,29%
Op. Margin-956,94%

Veiligheid

Debt / Equity
0,01
Onder sectorgemiddelde (0,49)
Current Ratio2,21
Interest Coverage-134,82

Waardering

PE (TTM)
-6,56
Onder sectorgemiddelde (11,15)
P/B Ratio7,54
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Financial Services sector mediaan (2144 peers)
Metriek Aandeel Sector Mediaan
P/E -6,6 11,1
P/B 7,5 1,2
ROE % -144,8 9,2
Net Margin % -874,3 9,4
Rev Growth 5Y % — 5,8
D/E 0,0 0,5

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,36 M Net Income (TTM) -11,92 M
ROE -144,79% ROA -90,37%
Gross Margin 86,75% Operating Margin -956,94%
Net Margin -874,29% Free Cash Flow (TTM) -8,60 M
ROIC -107,38% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,01 Current Ratio 2,21
Interest Coverage -134,82 Asset Turnover 0,10
Working Capital 3,29 M Tangible Book Value 9,96 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -6,56 Forward P/E N/A
P/B Ratio 7,54 P/S Ratio 57,34
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -11,01%
Market Cap 78,16 M Enterprise Value 78,31 M
Per Share
EPS (Diluted TTM) -2,81 Revenue / Share 0,22
FCF / Share -1,38 OCF / Share -1,38
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 72,19%
SBC-Adj. FCF -8,70 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,36 M 0,0 0,0 0,0 —
Net Income -11,92 M -10,88 M -21,27 M -37,57 M 15,23 M
EPS (Diluted) -2,81 -5,65 -0,83 -2,63 —
Gross Profit 1,18 M 0,0 0,0 0,0 —
Operating Income -13,04 M -10,05 M -21,49 M -34,20 M -681.319,0
EBITDA — — — — —
R&D Expenses 1,28 M 2,33 M 6,67 M 20.887,0 —
SG&A Expenses — — — — —
D&A 1,18 M 1,00 M 1,00 M 1,00 M —
Interest Expense 96.744,0 396.116,0 107.685,0 218.412,0 —
Income Tax 0,0 0,0 0,0 0,0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 16,15 M 8,91 M 8,07 M 7,92 M 76,17 M
Total Liabilities 2,09 M 5,04 M 3,76 M 3,11 M 7,19 M
Shareholders' Equity 13,56 M 3,19 M 4,31 M 4,80 M -6,77 M
Total Debt 150.000,0 — 1,13 M 150.000,0 —
Cash & Equivalents — — — — 404.345,0
Current Assets 7,35 M 1,05 M 5,25 M 3,94 M 412.678,0
Current Liabilities 1,77 M 4,51 M 2,99 M 1,82 M 139.927,0